Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial by Yokota, Shumpei, Prof, Imagawa, Tomoyuki, MD, Mori, Masaaki, MD, Miyamae, Takako, MD, Aihara, Yukoh, MD, Takei, Shuji, Prof, Iwata, Naomi, MD, Umebayashi, Hiroaki, MD, Murata, Takuji, MD, Miyoshi, Mari, MD, Tomiita, Minako, MD, Nishimoto, Norihiro, Prof, Kishimoto, Tadamitsu, Prof

Get full text